Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
More than 40 types of Amyloid proteins are discovered till date
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
Padmanabhan brings over two decades of extensive experience in FMCG sector
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Subscribe To Our Newsletter & Stay Updated